Octagon Capital Partners
24
115M
18
0.77
1
0.17
7
- Areas of investment
Summary
Octagon Capital Partners is the famous VC, which was founded in 1993. The fund was located in North America if to be more exact in Canada. The main office of represented VC is situated in the Toronto.
Among the most popular portfolio startups of the fund, we may highlight SinoHub. For fund there is no match between the country of its foundation and the country of its the most frequent investments - China. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Supply Chain Management, Hardware.
The high activity for fund was in 2010. The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 1 - 5 millions dollars.
The typical case for the fund is to invest in rounds with 8 participants. The meaningful sponsors for the fund in investment in the same round are Whitebox Advisors, Ramius Capital, Paragon Capital.
Investments analytics
Analytics
- Total investments
- 24
- Lead investments
- 1
- Exits
- 7
- Rounds per year
- 0.77
- Follow on index
- 0.17
- Investments by industry
- Biotechnology (15)
- Health Care (8)
- Pharmaceutical (4)
- Life Science (4)
- Therapeutics (3) Show 24 more
- Investments by region
-
- China (7)
- United States (12)
- Canada (4)
- Peak activity year
- 2020
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 37M
- Group Appearance index
- 0.92
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Happay | 23 Apr 2015 | Software, Financial Services, FinTech, SaaS | Seed | 500K | Karnataka, India, Bengaluru |
| Immvira | 31 Dec 2020 | Clinical Trials | Late Stage Venture | 0 | Guangdong Province, Futian District, China |
| Taysha Gene Therapies | 05 Aug 2020 | Biotechnology, Genetics, Life Science | Early Stage Venture | 95M | United States, Texas, Dallas |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.